Publications by authors named "J M Wortham"

Background: People with chronic kidney disease (CKD) have a higher risk for progression to tuberculosis disease following infection with Mycobacterium tuberculosis. We produced a nationwide incidence estimate and description of tuberculosis among people with kidney failure.

Methods: We completed a cross-sectional descriptive analysis of people with a reported case of tuberculosis in the United States between 2010 and 2021.

View Article and Find Full Text PDF

BACKGROUNDCulture-based diagnostics are the gold standard for diagnosing pulmonary TB (PTB). We characterized culture practices by comparing cases with documented sputum culture to those without.METHODSUsing multivariable logistic regression, we examined associations between PTB case characteristics and no documented sputum culture reported to the U.

View Article and Find Full Text PDF

During July 7-11, 2023, CDC received reports of two patients in different states with a tuberculosis (TB) diagnosis following spinal surgical procedures that used bone allografts containing live cells from the same deceased donor. An outbreak associated with a similar product manufactured by the same tissue establishment (i.e.

View Article and Find Full Text PDF

Objective: Death from tuberculosis or HIV among people from racial and ethnic minority groups who are aged <65 years is a public health concern. We describe age-adjusted, absolute, and relative death rates from HIV or tuberculosis from 2011 through 2020 by sex, race, and ethnicity among US residents.

Methods: We used mortality data from the Centers for Disease Control and Prevention online data system on deaths from multiple causes from 2011 through 2020 to calculate age-adjusted death rates and absolute and relative disparities in rates of death by sex, race, and ethnicity.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines the prescribing patterns for latent tuberculosis infection treatments in the U.S. since updated CDC guidelines introduced shorter regimens in 2011.
  • Researchers analyzed data from over 20,000 high-risk individuals and found that a significant majority were treated with the more efficient 4-month rifampin regimen.
  • There has been a notable increase in the adoption of these shorter treatment regimens, rising from 55% in 2013 to 81% by late 2016, indicating a shift in practice.
View Article and Find Full Text PDF